Clinical Articles

The following section outlines the clinical papers, posters and proposals that refer to the clinical use of MRL mushroom nutrition products. This information is for healthcare practitioners only and should not be provided to members of the general public.
Download PDF

The present study investigated the bioaccessibility and bioavailability of bioactive compounds present in Trametes versicolor (TV), Hericium erinaceus (HE), and Pleurotus ostreatus (PO) species, following simulated gastrointestinal digestion (GID), with a special focus on polysaccharide and protein fractions. Biochemical characterization revealed that polysaccharides were the most prevalent, varying between 76.15 and 80.45 % of dry weight (DW) without significant differences between species. (1→4)-α-glucans were the most abundant, followed by (1→4)-β-glucans. A wide distribution of MW was found in the polysaccharide fraction, with a higher concentration of polysaccharides over 107 kDa. Protein content ranged from 4.08 to 6.28 % DW in the three species, with TV exhibiting significantly higher content of total and soluble protein.

The mushroom biomasses used in this study were supplied by Mycology Research Laboratories Ltd.